Login

The Director and Co-Head of UK Corporate Finance at Houlihan Lokey specializes in the food & beverage sector, offering expert advisory services. 00:10:00

Share On Facebook Share On Twitter

Scott Beiser is a Co-Chairman of Houlihan Lokey

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Interview with Alice Queen: Advancing Gold Exploration in Australia's Horn Island
00:10:00
Michael Mervis on Building the Court's Trust | Michael T. Mervis - Partner, Proskauer Rose LLP
00:00:00
Kancera – 5 mar 2024 - Peter Selin, CEO, Kancera
00:10:00
Seeks to invest in early-stage technology-enabled education companies|Scott Pulsipher,General Partner,Juvo Ventures
00:10:00
Balancing Growth and Capital Preservation: Mark Burgess on the Bennelong Kardinia Absolute Return Fund | Mark Burgess - Portfolio Manager, Kardinia Capital
00:10:00
Stephen Schwarzman on the Fitch Downgrade and U.S. Political Landscape | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
Greg Brown, CEO of hipages Group Holdings Pty Ltd, speaks at the ASX Small and Mid-Cap Conference in March 2024.
00:10:00
Ciena CEO Gary Smith discusses the company's distinctive focus on customer engagement.
00:10:00
Mr. Jakaria Shahid, Founder & CEO of Edison Group, discusses his experience with Standard Chartered Saadiq from an Islamic scholar's perspective.
00:10:00
Advantages of Large-Capacity Batteries for Underground Mining EVs
00:10:00
Cambrian ventures is a 20M dollar fintech focused fund|Rex Salisbury,General Partner,Cambrian Ventures
00:10:00
3D Metalforge transforms supply chains with additive manufacturing technology | Matt Waterhouse , CEO ,3D Metal Forge Ltd.

© 2017 - Neuhu+